Treatment with anti-PD-L1 Ab alone did not significantly reduce tumor volume (717±62mm3, p=1.00), whereas PLX4720 treatment resulted in significant tumor volume reduction (439±188 mm3, 44% tumor reduction, P = 0.007). The gene discussed is CD274; the disease is neoplasm.